variety radionuclides continue investigated clinically used different therapeutic applications nuclear medicine choice particular radionuclide regard appropriate emissions linear energy transfer physical dictated large extent character disease solid tumor metastatic disease carrier used selectively transport radionuclide desired site impressive body information appeared recent literature addresses considerations article summarizes discusses recent advances progress clinical applications therapeutic radionuclides relatively new developing areas radioimmunotherapy peptide therapy intravascular therapy prevent restenosis radiation synovectomy bone malignancy therapy projections future directions progress areas crucial issue reliable supply new emerging therapeutic radionuclides quantities sufficient initially research routine clinical use worthy goal united states remains achieved references NUMBER half life year round